Company news
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A (SSE:600513) news
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Oct 14, 2025: Announcement on Outline of the 2025 Semi-annual Performance…
Press releases — page 2
Announcement on Outline of the 2025 Semi-annual Performance Briefing
October 13, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
September 30, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 25, 2025
Announcement on Electing Employee Representative Director
September 18, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 15, 2025
Announcement on Resolutions of the 15th Extraordinary Meeting of the 9th Board of Directors
September 12, 2025
Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025
August 26, 2025
Announcement on the Change of Disclosure Date for the 2025 Semi-annual Report
August 25, 2025
Announcement on Receiving Results of GMP Compliance Inspection Concerning Drugs by the Wholly-owned Subsidiary
August 19, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
August 11, 2025
Announcement on Holding Subsidiary’s Drug Passing Generic Drug Consistency Evaluation
August 4, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
July 24, 2025